TIAA CREF Investment Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q2 | – | Sell |
-10,161
| Closed | -$108K | – | 3138 |
|
2018
Q1 | $108K | Sell |
10,161
-12,730
| -56% | -$135K | ﹤0.01% | 3012 |
|
2017
Q4 | $965K | Buy |
22,891
+7,895
| +53% | +$333K | ﹤0.01% | 2480 |
|
2017
Q3 | $825K | Buy |
14,996
+4,662
| +45% | +$256K | ﹤0.01% | 2616 |
|
2017
Q2 | $1.92M | Buy |
10,334
+2,001
| +24% | +$371K | ﹤0.01% | 2210 |
|
2017
Q1 | $996K | Sell |
8,333
-819
| -9% | -$97.9K | ﹤0.01% | 2505 |
|
2016
Q4 | $909K | Sell |
9,152
-587
| -6% | -$58.3K | ﹤0.01% | 2589 |
|
2016
Q3 | $1.09K | Buy |
9,739
+248
| +3% | +$28 | ﹤0.01% | 2497 |
|
2016
Q2 | $975K | Buy |
9,491
+4,214
| +80% | +$433K | ﹤0.01% | 2520 |
|
2016
Q1 | $485K | Hold |
5,277
| – | – | ﹤0.01% | 2794 |
|
2015
Q4 | $761K | Hold |
5,277
| – | – | ﹤0.01% | 2737 |
|
2015
Q3 | $545K | Buy |
+5,277
| New | +$545K | ﹤0.01% | 2862 |
|